| Patents for A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316) |
|---|
| 01/11/2001 | WO2001001923A2 Composition based on fluorinated polymer and alpha-hydroxy-acid salt for topical use for skin protection |
| 01/11/2001 | WO2001001782A1 Pain relief composition and method of relieving pain |
| 01/11/2001 | WO2000059519A3 Active agent and combination of active agents for human beings and animals |
| 01/11/2001 | WO2000057840A3 Dermatological topical composition |
| 01/11/2001 | WO2000053215A3 Deglycosylated ricin toxin a-chain vaccine |
| 01/11/2001 | CA2380875A1 Cell death related drug targets in yeast and fungi |
| 01/11/2001 | CA2374035A1 Pain relief composition and method of relieving pain |
| 01/10/2001 | EP1066835A1 Composition containing the pepino extracts for lowering the concentration of alcohol in the blood and method for producing the same |
| 01/10/2001 | EP1066824A2 Stimulative agent and stimulative perfume composition |
| 01/10/2001 | EP1066042A2 Steroidal saponins for treating alzheimer's disease |
| 01/10/2001 | EP1066033A1 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease |
| 01/10/2001 | EP1066015A1 Topical liquid composition for promoting hair growth and process of manufacturing thereof |
| 01/10/2001 | EP1065946A1 Natural substance based agent |
| 01/10/2001 | EP0796103B1 Use of incense in the treatment of alzheimer's disease |
| 01/10/2001 | EP0656932B1 Process for dewaxing citrus oils |
| 01/10/2001 | CN1060392C Medicine for curing recurrent stomatocace and Behcet's syndrome |
| 01/10/2001 | CN1060346C Chinese drug 'Linshuiling Capsule' for curing hydrops and preparing process |
| 01/09/2001 | US6171594 Adhesive agent and use of such agent |
| 01/09/2001 | US6171593 Method of treating skin disorders using an extract of mullein |
| 01/09/2001 | US6171588 Anti-αvβ3 integrin antibody antagonists |
| 01/04/2001 | WO2001000682A1 Hematopoietic arabinogalactan composition |
| 01/04/2001 | WO2001000215A1 Compositions for treating or preventing neurodegeneration and cognitive decline |
| 01/04/2001 | WO2001000203A1 Use of creatine or creatine compounds for skin preservation |
| 01/04/2001 | WO2001000199A1 Compounds obtained from salvia species having antiviral activity |
| 01/04/2001 | WO2001000038A1 An effervescent green tea extract formulation |
| 01/04/2001 | WO2001000034A1 Pesticidal compositions containing peppermint oil |
| 01/04/2001 | WO2001000032A1 Pesticidal compositions containing rosemary oil |
| 01/04/2001 | WO1999062451A8 Topical transdermal treatments |
| 01/04/2001 | CA2376922A1 Compounds obtained from salvia species having antiviral activity |
| 01/04/2001 | CA2375979A1 An effervescent green tea extract formulation |
| 01/03/2001 | EP1064932A1 Use of dedifferentiated plant cells |
| 01/03/2001 | EP1064923A1 Artificial skin tanning compositions |
| 01/03/2001 | EP1064855A1 Foods, medical treatments and method relating to effects of promoting the growth of (lactobacillus bifidus), preventing allergy and lowering human cholesterol level |
| 01/03/2001 | EP1064009A1 Utilization of extracts from iris plants, cimicifuga racemosa and tectorigenin as an estrogen-like organ-selective medicament without uterotropic effects |
| 01/03/2001 | EP1064008A1 Use of at least one protein extract of the moringa genus plant seeds and corresponding cosmetic and/or pharmacological composition |
| 01/03/2001 | EP1063990A1 Therapy of estrogen-associated disorders |
| 01/03/2001 | EP1063988A1 Hesperidin and hesperetin as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor ofmacrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases |
| 01/03/2001 | EP1063980A2 Methods for decreasing beta amyloid protein production |
| 01/03/2001 | EP1063978A1 Method of treating neuroma pain |
| 01/03/2001 | EP1063960A1 Composition for aroma delivery |
| 01/03/2001 | EP0934060A4 Dietary supplements |
| 01/03/2001 | EP0902624B1 Composition and its use as a food supplement or for lowering lipids in serum |
| 01/03/2001 | EP0656890B1 Novel method for preparing ergothioneine |
| 01/03/2001 | CN1060060C Use of anti-anxiety medicine made from dry ginger and ginkgo |
| 01/02/2001 | US6169118 Two flavoring oils and lauryl alcohol for use in an orally administered formulation |
| 01/02/2001 | US6169069 Therapeutic/cosmetic compositions comprising CGRP antagonists for treating the eyes or eyelids |
| 01/02/2001 | US6168802 In the last few years there has been considerable interest among athletes in creatine, which occurs abundantly in skeletal muscle. |
| 01/02/2001 | US6168799 β-D-glucan topical composition |
| 01/02/2001 | US6168795 Method for anticancer therapy using an herbal extract composition |
| 01/02/2001 | US6168794 Compositions comprising oleum Melaleuca |
| 01/02/2001 | CA2312526A1 Use of dedifferentiated plant cells |
| 01/02/2001 | CA2312433A1 Compounds for artificially colouring the skin and uses |
| 12/28/2000 | WO2000078980A1 Method for producing plants with increased flavonoid and phenolic compound content |
| 12/28/2000 | WO2000078326A1 Method and composition for preventing or treating adverse physiological effects associated with cardiac disease |
| 12/28/2000 | WO2000078324A1 The leaves of cajanus cajan(l.) millsp and extract, formulation and uses thereof |
| 12/28/2000 | WO2000078323A1 A use of icariin in preparing the medicine for preventing and treating sexual disorder and vasoconstrictive diseases |
| 12/28/2000 | WO2000078143A1 Method of increasing the content of flavonoids and phenolic substances in plants |
| 12/28/2000 | DE19911680A1 New extracts and compounds from Ganoderma pfeifferi , useful e.g. as antibacterial and antiviral agents, preservatives, cosmetic, pharmaceutical and food additives and in fish farming, are protease inhibitors |
| 12/28/2000 | CA2340319A1 Method for producing plants with increased flavonoid and phenolic compound content |
| 12/27/2000 | EP1062871A1 Bactericides |
| 12/27/2000 | EP1061963A1 Protease inhibitors in absorbent articles |
| 12/27/2000 | EP1061962A1 Disposable absorbent article having a skin care composition containing an enzyme inhibitor |
| 12/27/2000 | EP1061895A1 Synergetic composition comprising a compound with lipoaminoacid structure and a tuberous water-lily extract |
| 12/27/2000 | EP1061887A1 Novel use of phospholipids of vegetable and animal origin in nutritional therapy |
| 12/27/2000 | EP1061812A1 Food products having enhanced cocoa polyphenol content and processes for producing same |
| 12/27/2000 | EP0717613B1 Stable composition containing wheat sprout juice and process for producing it |
| 12/27/2000 | EP0554319B1 Antimicrobial composition |
| 12/27/2000 | CN1278182A Citrus peel extract as inhibitor of acyl CoA-cholesterol-0-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall |
| 12/27/2000 | CN1278181A Method for treating diabetes, hyperglycemia and hypoglycemia |
| 12/27/2000 | CN1278171A Naringin and naringenin as inhibitor of acyl coa-cholesterol-o-acyltransferase, ihibitor of macrophage-lipid complex accumulation on the arterial wall and preventive agent |
| 12/27/2000 | CN1278170A Hesperidin and hesperetin as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive agent |
| 12/26/2000 | US6165984 Administering an effective amount of naringin or naringenin to the human to prevent acylcoa-cholesterol-o-acyltransferase activity to treat hepatic diseases; inhibiting accumulation of macrophage-lipid complex on the arterial endothelium |
| 12/26/2000 | US6165539 Food supplement composition |
| 12/26/2000 | US6165474 Application for patent for nutriceutical chew toy |
| 12/21/2000 | WO2000077133A1 Fat compositions |
| 12/21/2000 | WO2000076546A1 Producing meat with enhanced shelf-life |
| 12/21/2000 | WO2000076492A1 Nutrient formulations for disease reduction, and related treatment and component screening methods |
| 12/21/2000 | WO2000076475A1 Prophylactic, therapeutic and industrial antioxidant compositions enhanced with stabilized atomic hydrogen/free electrons and methods to prepare and use such compositions |
| 12/21/2000 | WO2000076464A2 Oxidatively stable, long-chain ethyl ester emollients |
| 12/21/2000 | WO2000053030A3 Pet food product with coconut endosperm fibre |
| 12/21/2000 | WO2000051445A3 Soluble plant derived natural color concentrates and antimicrobial nutraceuticals |
| 12/21/2000 | WO2000025588A8 Anti-snoring composition |
| 12/21/2000 | DE19927574A1 Increasing content of flavonoids and phenols in plants, useful for e.g. preventing cardiovascular disease, by reducing activity of flavanone-3-hydroxylase |
| 12/21/2000 | DE19927571A1 Increasing the levels of flavonoids and phenolic compounds in plants comprises treating the plants with growth-regulating 4-acyl-3,5-dioxo-1-cyclohexanecarboxylic acid derivatives |
| 12/21/2000 | CA2377414A1 Nutrient formulations for disease reduction, and related treatment and component screening methods |
| 12/21/2000 | CA2377232A1 Prophylactic, therapeutic and industrial antioxidant compositions enhanced with stabilized atomic hydrogen/free electrons and methods to prepare and use such compositions |
| 12/20/2000 | EP1060744A1 Preventives/remedies for osteoporosis |
| 12/20/2000 | EP1059930A1 Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a nsaid |
| 12/20/2000 | CN1277555A Composition for improving mental capabilities in mammals |
| 12/20/2000 | CN1277035A Volatile liquid composition for inhibiting hyperglycemia, and its volatiling device and its use |
| 12/19/2000 | US6162479 Citrus based spiro ethers as anti-fast-pass effect agents used as dietary supplement or medical food |
| 12/19/2000 | US6162458 Patch for beautification |
| 12/19/2000 | US6162438 Herbal compositions and their use as agents for control of hypertension, hypercholesterolemia and hyperlipidemia |
| 12/19/2000 | US6162437 Treating hepatocirrhosis |
| 12/19/2000 | US6162393 Contact lens and ophthalmic solutions |
| 12/17/2000 | CA2311887A1 Purslane powder food supplement |
| 12/14/2000 | WO2000075284A1 A bacterial strain, processed plant extracts and probiotic compositions for human and veterinary use |
| 12/14/2000 | WO2000075282A1 Method for obtaining from a culture medium of microalgae, a heat-stable extract with antioxidant and wound healing activity |
| 12/14/2000 | WO2000074722A2 Modification of biological elements |
| 12/14/2000 | WO2000074699A1 Extracts of feverfew (tanacetum parthenium) against inflammatory disorders |